| Breakdown | Jun 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -19.32K | 1.62K | -3.63K | 0.00 |
| EBITDA | -4.69M | -2.98M | -2.84M | -2.01M | -2.02M |
| Net Income | -25.77M | -3.04M | -3.20M | -2.78M | -1.94M |
Balance Sheet | |||||
| Total Assets | 1.69M | 23.50M | 26.50M | 24.40M | 17.82M |
| Cash, Cash Equivalents and Short-Term Investments | 923.00K | 1.94M | 6.67M | 10.03M | 1.56M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 826.00K | 346.00K | 1.03M | 1.83M | 923.18K |
| Stockholders Equity | 859.00K | 23.16M | 25.47M | 22.56M | 16.89M |
Cash Flow | |||||
| Free Cash Flow | -3.79M | -4.97M | -9.39M | -5.03M | -4.96M |
| Operating Cash Flow | -3.58M | -3.24M | -4.34M | -2.36M | -1.30M |
| Investing Cash Flow | -201.00K | -1.73M | -5.05M | -2.70M | -3.65M |
| Financing Cash Flow | 2.77M | 225.00K | 5.87M | 13.54M | 2.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | £35.25M | -9.13 | >-0.01% | ― | ― | -19.57% | |
49 Neutral | £67.62M | 0.59 | 1.23% | ― | ― | ― | |
48 Neutral | £26.52M | -12.41 | -9110.55% | ― | ― | ― | |
48 Neutral | £8.31M | -163.55 | -14.14% | ― | ― | ― | |
45 Neutral | £33.84M | -1.74 | -73.36% | ― | ― | ― | |
42 Neutral | £17.91M | ― | ― | ― | ― | ― |
Emmerson has reported progress in its arbitration proceedings against the Government of the Kingdom of Morocco, confirming that the ICSID arbitration panel was fully constituted in the fourth quarter of 2025 with the appointment of tribunal president Laurent Lévy and that an initial hearing on procedural matters took place on 16 December 2025, resulting in a timetable requiring the company to submit its detailed Memorial by the end of the first quarter of 2026. The case, brought by Emmerson’s subsidiaries Khemisset UK Ltd and Potasse de Khemisset S.A., seeks compensation for alleged expropriation of its Khemisset project and related treaty breaches under the UK-Morocco investment agreement, marking a critical legal process whose outcome remains uncertain but is central to the company’s efforts to recover value from its Moroccan investment.
The most recent analyst rating on (GB:EML) stock is a Hold with a £2.00 price target. To see the full list of analyst forecasts on Emmerson stock, see the GB:EML Stock Forecast page.